ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,463Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 251

$608K Total Retail Price of All Prescriptions

Rank: 8 out of 251

489 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Hampshire
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 489 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

13% of this provider’s 489 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 9,551 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Hampshire
SIMVASTATIN 504 459 1 1
AMLODIPINE BESYLATE 446 415 2 4
OMEPRAZOLE 321 269 3 5
LEVOTHYROXINE SODIUM 320 290 4 3
ATORVASTATIN CALCIUM 289 285 5 8
FUROSEMIDE 276 247 6 6
LISINOPRIL 214 201 7 2
METOPROLOL SUCCINATE 205 185 8 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 197 177 9 48
PREDNISONE 186 175 10 27
ATENOLOL 182 180 11 12
METOPROLOL TARTRATE 182 167 11 7
LOVASTATIN 174 135 13 31
CITALOPRAM HBR 169 157 14 15
ADVAIR DISKUS 152 144 15 25
HYDROCHLOROTHIAZIDE 148 134 16 9
SERTRALINE HCL 143 131 17 22
DONEPEZIL HCL 139 139 18 29
HYDROCODONE-ACETAMINOPHEN 136 121 S3 19 18
TRAMADOL HCL 127 125 20 24
METFORMIN HCL 127 115 20 10
CRESTOR 127 97 20 21
GLIMEPIRIDE 112 110 23 62
POLYETHYLENE GLYCOL 3350 108 108 24 40
WARFARIN SODIUM 105 105 25 11
KLOR-CON M20 102 100 26 45
CLOPIDOGREL 95 87 27 60
GABAPENTIN 93 87 28 16
ESCITALOPRAM OXALATE 89 88 29 43
POTASSIUM CHLORIDE 82 72 30 33
CARVEDILOL 82 82 30 41
SPIRIVA 81 69 32 37
DIOVAN 77 77 33 23
PROAIR HFA 76 61 34 42
DIOVAN HCT 76 76 34 107
CIPROFLOXACIN HCL 67 59 36 94
RISPERIDONE 66 64 37 46
LOSARTAN-HYDROCHLOROTHIAZIDE 66 64 37 95
CARBIDOPA-LEVODOPA 66 66 37 67
DILTIAZEM 24HR CD 66 66 37 93
RANITIDINE HCL 65 65 41 35
NEXIUM 64 51 42 28
SYNTHROID 63 63 43 71
ALLOPURINOL 62 58 44 34
PAROXETINE HCL 62 62 44 63
GEMFIBROZIL 62 32 44 98
MIRTAZAPINE 61 61 47 36
AZITHROMYCIN 59 52 48 59
PLAVIX 59 58 48 100
VENLAFAXINE HCL ER 57 57 50 58
ZOLPIDEM TARTRATE 57 46 50 19
PANTOPRAZOLE SODIUM 56 54 52 20
PRAVASTATIN SODIUM 53 48 53 14
NAMENDA 52 52 54 44
FLUOXETINE HCL 52 51 54 52
DOXAZOSIN MESYLATE 52 48 54 97
METFORMIN HCL ER 50 50 57 65
OLANZAPINE 50 50 57 90
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 22, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.